CSF-Based Volumetric Imaging Biomarkers Highlight Incidence and Risk Factors for Cerebral Edema After Ischemic Stroke.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 24 01 2023
accepted: 19 04 2023
pmc-release: 01 02 2025
medline: 13 2 2024
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Cerebral edema has primarily been studied using midline shift or clinical deterioration as end points, which only captures the severe and delayed manifestations of a process affecting many patients with stroke. Quantitative imaging biomarkers that measure edema severity across the entire spectrum could improve its early detection, as well as identify relevant mediators of this important stroke complication. We applied an automated image analysis pipeline to measure the displacement of cerebrospinal fluid (ΔCSF) and the ratio of lesional versus contralateral hemispheric cerebrospinal fluid (CSF) volume (CSF ratio) in a cohort of 935 patients with hemispheric stroke with follow-up computed tomography scans taken a median of 26 h (interquartile range 24-31) after stroke onset. We determined diagnostic thresholds based on comparison to those without any visible edema. We modeled baseline clinical and radiographic variables against each edema biomarker and assessed how each biomarker was associated with stroke outcome (modified Rankin Scale at 90 days). The displacement of CSF and CSF ratio were correlated with midline shift (r = 0.52 and - 0.74, p < 0.0001) but exhibited broader ranges. A ΔCSF of greater than 14% or a CSF ratio below 0.90 identified those with visible edema: more than half of the patients with stroke met these criteria, compared with only 14% who had midline shift at 24 h. Predictors of edema across all biomarkers included a higher National Institutes of Health Stroke Scale score, a lower Alberta Stroke Program Early CT score, and lower baseline CSF volume. A history of hypertension and diabetes (but not acute hyperglycemia) predicted greater ΔCSF but not midline shift. Both ΔCSF and a lower CSF ratio were associated with worse outcome, adjusting for age, National Institutes of Health Stroke Scale score, and Alberta Stroke Program Early CT score (odds ratio 1.7, 95% confidence interval 1.3-2.2 per 21% ΔCSF). Cerebral edema can be measured in a majority of patients with stroke on follow-up computed tomography using volumetric biomarkers evaluating CSF shifts, including in many without visible midline shift. Edema formation is influenced by clinical and radiographic stroke severity but also by chronic vascular risk factors and contributes to worse stroke outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Cerebral edema has primarily been studied using midline shift or clinical deterioration as end points, which only captures the severe and delayed manifestations of a process affecting many patients with stroke. Quantitative imaging biomarkers that measure edema severity across the entire spectrum could improve its early detection, as well as identify relevant mediators of this important stroke complication.
METHODS METHODS
We applied an automated image analysis pipeline to measure the displacement of cerebrospinal fluid (ΔCSF) and the ratio of lesional versus contralateral hemispheric cerebrospinal fluid (CSF) volume (CSF ratio) in a cohort of 935 patients with hemispheric stroke with follow-up computed tomography scans taken a median of 26 h (interquartile range 24-31) after stroke onset. We determined diagnostic thresholds based on comparison to those without any visible edema. We modeled baseline clinical and radiographic variables against each edema biomarker and assessed how each biomarker was associated with stroke outcome (modified Rankin Scale at 90 days).
RESULTS RESULTS
The displacement of CSF and CSF ratio were correlated with midline shift (r = 0.52 and - 0.74, p < 0.0001) but exhibited broader ranges. A ΔCSF of greater than 14% or a CSF ratio below 0.90 identified those with visible edema: more than half of the patients with stroke met these criteria, compared with only 14% who had midline shift at 24 h. Predictors of edema across all biomarkers included a higher National Institutes of Health Stroke Scale score, a lower Alberta Stroke Program Early CT score, and lower baseline CSF volume. A history of hypertension and diabetes (but not acute hyperglycemia) predicted greater ΔCSF but not midline shift. Both ΔCSF and a lower CSF ratio were associated with worse outcome, adjusting for age, National Institutes of Health Stroke Scale score, and Alberta Stroke Program Early CT score (odds ratio 1.7, 95% confidence interval 1.3-2.2 per 21% ΔCSF).
CONCLUSIONS CONCLUSIONS
Cerebral edema can be measured in a majority of patients with stroke on follow-up computed tomography using volumetric biomarkers evaluating CSF shifts, including in many without visible midline shift. Edema formation is influenced by clinical and radiographic stroke severity but also by chronic vascular risk factors and contributes to worse stroke outcomes.

Identifiants

pubmed: 37188885
doi: 10.1007/s12028-023-01742-0
pii: 10.1007/s12028-023-01742-0
pmc: PMC11025464
mid: NIHMS1982389
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

303-313

Subventions

Organisme : NINDS NIH HHS
ID : R01NS121218
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS107230
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085419
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS085419
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS099440
Pays : United States
Organisme : NINDS NIH HHS
ID : U24NS107230
Pays : United States
Organisme : NINDS NIH HHS
ID : K23NS099487
Pays : United States
Organisme : NINDS NIH HHS
ID : K23NS099440
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS099487
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS121218
Pays : United States

Informations de copyright

© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

Stroke. 1986 Sep-Oct;17(5):865-71
pubmed: 3764956
Stroke. 2018 Aug;49(8):1906-1912
pubmed: 29976584
Stroke. 2020 Feb;51(2):462-467
pubmed: 31818229
AJNR Am J Neuroradiol. 2001 Sep;22(8):1534-42
pubmed: 11559501
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Arch Neurol. 1996 Apr;53(4):309-15
pubmed: 8929152
Stroke. 2014 Dec;45(12):3643-8
pubmed: 25336512
Front Neurol. 2018 Aug 21;9:687
pubmed: 30186224
Front Neurol. 2022 Jun 27;13:898728
pubmed: 35832178
Cerebrovasc Dis. 2014;38(1):39-45
pubmed: 25228461
Stroke. 2021 Jan;52(1):132-141
pubmed: 33317415
Int J Stroke. 2013 Oct;8(7):529-34
pubmed: 22405327
Front Neurol. 2020 Nov 10;11:582767
pubmed: 33240206
Environ Int. 2021 Feb;147:106364
pubmed: 33421766
Cerebrovasc Dis. 2010 Jan;29(2):137-9
pubmed: 19955737
J Neurol Sci. 2018 Sep 15;392:94-99
pubmed: 30031994
J Stroke. 2019 Sep;21(3):347-349
pubmed: 31590479
J Cereb Blood Flow Metab. 2018 Oct;38(10):1807-1817
pubmed: 28731381
Lancet Neurol. 2007 Mar;6(3):258-68
pubmed: 17303532
Stroke. 2019 Dec;50(12):3424-3430
pubmed: 31665994
JAMA Neurol. 2018 Apr 1;75(4):453-461
pubmed: 29365017
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 2011 Dec;42(12):3403-9
pubmed: 21903965
Acta Neurochir Suppl. 2016;121:223-6
pubmed: 26463953
Neurosci Lett. 2020 Apr 17;724:134879
pubmed: 32126249
Neurocrit Care. 2016 Jun;24(3):420-7
pubmed: 26438467

Auteurs

Quoc Bui (Q)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.

Atul Kumar (A)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.

Yasheng Chen (Y)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.

Ali Hamzehloo (A)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.

Laura Heitsch (L)

Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Agnieszka Slowik (A)

Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.

Daniel Strbian (D)

Department of Neurology, Helsinki University Hospital, Helsinki, Finland.

Jin-Moo Lee (JM)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.

Rajat Dhar (R)

Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA. dharr@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH